• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    HCA Healthcare Reports Fourth Quarter 2024 Results and Provides 2025 Guidance

    1/24/25 7:30:00 AM ET
    $HCA
    Hospital/Nursing Management
    Health Care
    Get the next $HCA alert in real time by email

    HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the fourth quarter ended December 31, 2024.

    Key fourth quarter metrics (all percentage changes compare 4Q 2024 to 4Q 2023 unless otherwise noted):

    • Revenues totaled $18.285 billion
    • Net income attributable to HCA Healthcare, Inc. totaled $1.438 billion, or $5.63 per diluted share (which includes an estimated $0.60 per diluted share unfavorable impact from Hurricanes Helene and Milton)
    • Adjusted EBITDA totaled $3.712 billion
    • Cash flows from operating activities totaled $2.559 billion
    • Same facility admissions increased 3.0 percent and same facility equivalent admissions increased 3.1 percent

    "We finished 2024 with strong business fundamentals that were consistent with previous quarters," said Sam Hazen, Chief Executive Officer of HCA Healthcare. "The first half of the current decade, which ended in 2024, proved to be another period of long-term growth for the company and resulted in operational improvements across key performance indicators and greater value for our patients, employees and shareholders. These accomplishments are a testament to the incredible work of our teams, and position us well for the future."

    Revenues in the fourth quarter of 2024 totaled $18.285 billion, compared to $17.303 billion in the fourth quarter of 2023. Net income attributable to HCA Healthcare, Inc. totaled $1.438 billion, or $5.63 per diluted share, compared to $1.607 billion, or $5.93 per diluted share, in the fourth quarter of 2023. Results for the fourth quarter of 2024 include losses on sales of facilities of $195 million, or $0.59 per diluted share, primarily related to the pending sale of a hospital facility in California. Results for the fourth quarter of 2023 include gains on sales of facilities of $7 million, or $0.03 per diluted share.

    For the fourth quarter of 2024, Adjusted EBITDA totaled $3.712 billion, compared to $3.618 billion in the fourth quarter of 2023. Adjusted EBITDA is a non-GAAP financial measure. A table providing supplemental information on Adjusted EBITDA and reconciling net income attributable to HCA Healthcare, Inc. to Adjusted EBITDA is included in this release.

    Same facility admissions increased 3.0 percent and same facility equivalent admissions increased 3.1 percent in the fourth quarter of 2024, compared to the prior year period. Same facility emergency room visits increased 2.4 percent in the fourth quarter of 2024, compared to the prior year period. Same facility inpatient surgeries increased 2.8 percent, and same facility outpatient surgeries declined 1.3 percent in the fourth quarter of 2024, compared to the same period of 2023. Same facility revenue per equivalent admission increased 2.9 percent in the fourth quarter of 2024, compared to the fourth quarter of 2023.

    Year Ended December 31, 2024

    Revenues for the year ended December 31, 2024 totaled $70.603 billion, compared to $64.968 billion for the year ended December 31, 2023. Net income attributable to HCA Healthcare, Inc. was $5.760 billion, or $22.00 per diluted share, compared to $5.242 billion, or $18.97 per diluted share, for the year ended December 31, 2023. Results for the year ended December 31, 2024 include gains on sales of facilities of $14 million, or $0.04 per diluted share. Results for the year ended December 31, 2023 included losses on sales of facilities of $5 million, or $0.04 per diluted share.

    For 2024, Adjusted EBITDA totaled $13.882 billion, compared to $12.726 billion in 2023. Adjusted EBITDA is a non-GAAP financial measure. A table providing supplemental information on Adjusted EBITDA and reconciling net income attributable to HCA Healthcare, Inc. to Adjusted EBITDA is included in this release.

    Balance Sheet and Cash Flows from Operations

    As of December 31, 2024, HCA Healthcare, Inc.'s balance sheet reflected cash and cash equivalents of $1.933 billion, total debt of $43.031 billion, and total assets of $59.513 billion. During the fourth quarter of 2024, capital expenditures totaled $1.285 billion, excluding acquisitions. Cash flows provided by operating activities in the fourth quarter of 2024 totaled $2.559 billion, compared to $2.674 billion in the fourth quarter of 2023.

    During the fourth quarter of 2024, the Company repurchased 4.739 million shares of its common stock at a cost of $1.700 billion. The Company had $764 million remaining under its repurchase authorization as of December 31, 2024. As of December 31, 2024, the Company had $7.986 billion of availability under its credit facilities.

    Share Repurchase Program

    The HCA Healthcare, Inc. Board of Directors has authorized an additional share repurchase program for up to $10 billion of the Company's outstanding common stock. Repurchases will be made in accordance with applicable securities laws and may be made at management's discretion from time to time in the open market, through privately negotiated transactions, or otherwise. The repurchase program has no time limit and may be suspended for periods or discontinued at any time.

    Dividend

    HCA today announced that its Board of Directors declared a quarterly cash dividend of $0.72 per share on the Company's common stock. The dividend will be paid on March 31, 2025 to stockholders of record at the close of business on March 17, 2025.

    The declaration and payment of any future dividend will be subject to the discretion of the Board of Directors and will depend on a variety of factors, including the Company's financial condition, results of operations, and contractual restrictions. Future dividends are expected to be funded by cash balances and future cash flows from operations.

    Impact of Hurricanes

    During the fourth quarter of 2024, the Company incurred additional expenses and experienced loss of revenues estimated at $200 million, or $0.60 per diluted share, associated with Hurricane Helene's impact on its North Carolina facilities, as well as from Hurricane Milton, which impacted certain facilities in Florida.

    For the year ended December 31, 2024, the Company incurred additional expenses and experienced loss of revenues estimated at $250 million, or $0.73 per diluted share, associated with the impact of Hurricanes Helene and Milton on the Company's North Carolina facilities and certain facilities in Florida.

    These estimates do not include any insurance recoveries the Company may receive. All facilities impacted by Hurricanes Helene and Milton have resumed normal operations.

    2025 Guidance

    Today, the Company issued the following estimated guidance for 2025:

     

     

    2025 Guidance Range

    Revenues

     

    $72.80 to $75.80 billion

    Net Income Attributable to HCA Healthcare, Inc.

     

    $5.85 to $6.29 billion

    Adjusted EBITDA

     

    $14.30 to $15.10 billion

    EPS (diluted)

     

    $24.05 to $25.85 per diluted share

    Capital expenditures for 2025, excluding acquisitions, are estimated to be approximately $5.0 to $5.2 billion.

    The Company's guidance contains a number of assumptions, including, among others, the Company's current expectations regarding volume growth coupled with an anticipated mostly stable operating environment, payer mix, and the ongoing impacts of the two major hurricanes, the impact of current and future health care public policy developments, as well as general economic conditions, including inflation, and excludes the impact of items such as, but not limited to, gains or losses on sales of facilities, losses on retirement of debt, legal claims costs and impairment of long-lived assets.

    Adjusted EBITDA is a non-GAAP financial measure. A table reconciling forecasted net income attributable to HCA Healthcare, Inc. to forecasted Adjusted EBITDA is included in this release.

    The Company's guidance is based on current plans and expectations and are subject to a number of known and unknown uncertainties and risks, including those set forth below in the Company's "Forward-Looking Statements."

    Annual Stockholders' Meeting

    The Company's 2025 annual stockholders' meeting will be held virtually on April 24, 2025 at 2:00 p.m. Central Time for stockholders of record as of February 24, 2025.

    Earnings Conference Call

    HCA Healthcare will host a conference call for investors at 9:00 a.m. Central Time today. All interested investors are invited to access a live audio broadcast of the call via webcast. The broadcast also will be available on a replay basis beginning this afternoon. The webcast can be accessed through the Company's Investor Relations web page at https://investor.hcahealthcare.com/events-and-presentations/default.aspx.

    About the Company

    As of December 31, 2024, HCA operated 190 hospitals and approximately 2,400 ambulatory sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics, in 20 states and the United Kingdom.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the federal securities laws, which involve risks and uncertainties. Forward-looking statements include the Company's financial guidance for the year ending December 31, 2025, as well as other statements that do not relate solely to historical or current facts. Forward-looking statements can be identified by the use of words like "may," "believe," "will," "expect," "project," "estimate," "anticipate," "plan," "initiative" or "continue." These forward-looking statements are based on our current plans and expectations and are subject to a number of known and unknown uncertainties and risks, many of which are beyond our control, which could significantly affect current plans and expectations and our future financial position and results of operations. These factors include, but are not limited to, (1) changes in or related to general economic conditions nationally and regionally in our markets, including inflation and economic and business conditions (and the impact thereof on the economy, financial markets and banking industry); changes in revenues due to declining patient volumes; changes in payer mix (including increases in uninsured and underinsured patients); potential increased expenses related to labor, supply chain or other expenditures; workforce disruptions; supply shortages and disruptions (including as a result of geopolitical disruptions); and the impact of potential federal government shutdowns, (2) the impact of our significant indebtedness and the ability to refinance such indebtedness on acceptable terms, (3) the impact of current and future health care public policy developments and possible changes to other federal, state or local laws and regulations affecting the health care industry, including, but not limited to, the expiration of enhanced premium tax credits for individuals eligible to purchase insurance coverage through federal and state-based health insurance marketplaces, (4) the effects related to the implementation of sequestration spending reductions required under the Budget Control Act of 2011, related legislation extending these reductions, and the potential for future deficit reduction legislation that may alter these spending reductions, which include cuts to Medicare payments, or create additional spending reductions, (5) increases in the amount and risk of collectability of uninsured accounts and deductibles and copayment amounts for insured accounts, (6) the ability to achieve operating and financial targets, attain expected levels of patient volumes and revenues, and control the costs of providing services, (7) possible changes in Medicare, Medicaid and other state programs, including Medicaid supplemental payment programs, Medicaid waiver programs or state directed payments, that may impact reimbursements to health care providers and insurers and the size of the uninsured or underinsured population, (8) personnel-related capacity constraints, increases in wages and the ability to attract, utilize and retain qualified management and other personnel, including affiliated physicians, nurses and medical and technical support personnel, (9) the highly competitive nature of the health care business, (10) changes in service mix, revenue mix and surgical volumes, including potential declines in the population covered under third-party payer agreements, the ability to enter into and renew third-party payer provider agreements on acceptable terms and the impact of consumer-driven health plans and physician utilization trends and practices, (11) the efforts of health insurers, health care providers, large employer groups and others to contain health care costs, (12) the outcome of our continuing efforts to monitor, maintain and comply with appropriate laws, regulations, policies and procedures, (13) the availability and terms of capital to fund the expansion of our business and improvements to our existing facilities, (14) changes in accounting practices, (15) the emergence of and effects related to pandemics, epidemics and outbreaks of infectious diseases or other public health crises, (16) future divestitures which may result in charges and possible impairments of long-lived assets, (17) changes in business strategy or development plans, (18) delays in receiving payments for services provided, (19) the outcome of pending and any future tax audits, disputes and litigation associated with our tax positions, (20) the impact of known and unknown government investigations, litigation and other claims that may be made against us, (21) the impact of actual and potential cybersecurity incidents or security breaches involving us or our vendors and other third parties, (22) our ongoing ability to demonstrate meaningful use of certified electronic health record technology and the impact of interoperability requirements, (23) the impact of natural disasters, such as hurricanes and floods, including Hurricanes Milton and Helene, physical risks from climate change or similar events beyond our control on our assets and activities and the communities we serve, (24) changes in U.S. federal, state, or foreign tax laws including interpretive guidance that may be issued by taxing authorities or other standard setting bodies, (25) the results of our efforts to use technology and resilience initiatives, including artificial intelligence and machine learning, to drive efficiencies, better outcomes and an enhanced patient experience, (26) the impact of recent decisions of the U.S. Supreme Court regarding the actions of federal agencies, and (27) other risk factors described in our annual report on Form 10-K for the year ended December 31, 2023 and our other filings with the Securities and Exchange Commission. Many of the factors that will determine our future results are beyond our ability to control or predict. In light of the significant uncertainties inherent in the forward-looking statements contained herein, readers should not place undue reliance on forward-looking statements, which reflect management's views only as of the date hereof. We undertake no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. All references to "Company," "HCA" and "HCA Healthcare" as used throughout this release refer to HCA Healthcare, Inc. and its affiliates.

    HCA Healthcare, Inc.

    Condensed Consolidated Comprehensive Income Statements

    Fourth Quarter

    Unaudited

    (Dollars in millions, except per share amounts)

     

     

     

     

    2024

     

     

     

    2023

     

     

     

     

     

    Amount

     

     

    Ratio

     

     

     

    Amount

     

     

    Ratio

     

     

    Revenues

     

     

    $

    18,285

     

     

     

    100.0

     

    %

     

    $

    17,303

     

     

     

    100.0

     

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Salaries and benefits

     

     

     

    7,917

     

     

     

    43.3

     

     

     

     

    7,570

     

     

     

    43.7

     

     

    Supplies

     

     

     

    2,793

     

     

     

    15.3

     

     

     

     

    2,584

     

     

     

    14.9

     

     

    Other operating expenses

     

     

     

    3,873

     

     

     

    21.2

     

     

     

     

    3,559

     

     

     

    20.7

     

     

    Equity in earnings of affiliates

     

     

     

    (10

    )

     

     

    (0.1

    )

     

     

     

    (28

    )

     

     

    (0.2

    )

     

    Depreciation and amortization

     

     

     

    856

     

     

     

    4.6

     

     

     

     

    789

     

     

     

    4.5

     

     

    Interest expense

     

     

     

    528

     

     

     

    2.9

     

     

     

     

    491

     

     

     

    2.8

     

     

    Losses (gains) on sales of facilities

     

     

     

    195

     

     

     

    1.1

     

     

     

     

    (7

    )

     

     

    —

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    16,152

     

     

     

    88.3

     

     

     

     

    14,958

     

     

     

    86.4

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Income before income taxes

     

     

     

    2,133

     

     

     

    11.7

     

     

     

     

    2,345

     

     

     

    13.6

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Provision for income taxes

     

     

     

    447

     

     

     

    2.5

     

     

     

     

    484

     

     

     

    2.8

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Net income

     

     

     

    1,686

     

     

     

    9.2

     

     

     

     

    1,861

     

     

     

    10.8

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Net income attributable to noncontrolling interests

     

     

     

    248

     

     

     

    1.3

     

     

     

     

    254

     

     

     

    1.5

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Net income attributable to HCA Healthcare, Inc.

     

     

    $

    1,438

     

     

     

    7.9

     

     

     

    $

    1,607

     

     

     

    9.3

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Diluted earnings per share

     

     

    $

    5.63

     

     

     

     

     

     

    $

    5.93

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Shares used in computing diluted earnings per share (millions)

     

     

     

    255.310

     

     

     

     

     

     

     

    271.186

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Comprehensive income attributable to HCA Healthcare, Inc.

     

     

    $

    1,429

     

     

     

     

     

     

    $

    1,673

     

     

     

     

     

     

    HCA Healthcare, Inc.

    Condensed Consolidated Comprehensive Income Statements

    For the Years Ended December 31, 2024 and 2023

    Unaudited

    (Dollars in millions, except per share amounts)

     

     

     

    2024

     

     

     

    2023

     

     

     

     

    Amount

     

     

    Ratio

     

     

     

    Amount

     

     

    Ratio

     

     

    Revenues

     

    $

    70,603

     

     

     

    100.0

     

    %

     

    $

    64,968

     

     

     

    100.0

     

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Salaries and benefits

     

     

    31,170

     

     

     

    44.1

     

     

     

     

    29,487

     

     

     

    45.4

     

     

    Supplies

     

     

    10,755

     

     

     

    15.2

     

     

     

     

    9,902

     

     

     

    15.2

     

     

    Other operating expenses

     

     

    14,819

     

     

     

    21.0

     

     

     

     

    12,875

     

     

     

    19.8

     

     

    Equity in earnings of affiliates

     

     

    (23

    )

     

     

    —

     

     

     

     

    (22

    )

     

     

    —

     

     

    Depreciation and amortization

     

     

    3,312

     

     

     

    4.7

     

     

     

     

    3,077

     

     

     

    4.7

     

     

    Interest expense

     

     

    2,061

     

     

     

    2.9

     

     

     

     

    1,938

     

     

     

    3.0

     

     

    Losses (gains) on sales of facilities

     

     

    (14

    )

     

     

    —

     

     

     

     

    5

     

     

     

    —

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    62,080

     

     

     

    87.9

     

     

     

     

    57,262

     

     

     

    88.1

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Income before income taxes

     

     

    8,523

     

     

     

    12.1

     

     

     

     

    7,706

     

     

     

    11.9

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Provision for income taxes

     

     

    1,866

     

     

     

    2.7

     

     

     

     

    1,615

     

     

     

    2.5

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Net income

     

     

    6,657

     

     

     

    9.4

     

     

     

     

    6,091

     

     

     

    9.4

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Net income attributable to noncontrolling interests

     

     

    897

     

     

     

    1.2

     

     

     

     

    849

     

     

     

    1.3

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Net income attributable to HCA Healthcare, Inc.

     

    $

    5,760

     

     

     

    8.2

     

     

     

    $

    5,242

     

     

     

    8.1

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Diluted earnings per share

     

    $

    22.00

     

     

     

     

     

     

    $

    18.97

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Shares used in computing diluted earnings per share (millions)

     

     

    261.806

     

     

     

     

     

     

     

    276.412

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Comprehensive income attributable to HCA Healthcare, Inc.

     

    $

    5,798

     

     

     

     

     

     

    $

    5,307

     

     

     

     

     

    HCA Healthcare, Inc.

    Condensed Consolidated Balance Sheets

    Unaudited

    (Dollars in millions)

     

     

     

    December 31,

     

     

    September 30,

     

     

    December 31,

     

     

     

    2024

     

     

    2024

     

     

    2023

     

    ASSETS

     

     

     

     

     

     

     

     

     

    Current assets:

     

     

     

     

     

     

     

     

     

    Cash and cash equivalents

     

    $

    1,933

     

     

    $

    2,888

     

     

    $

    935

     

    Accounts receivable

     

     

    10,751

     

     

     

    9,915

     

     

     

    9,958

     

    Inventories

     

     

    1,738

     

     

     

    1,776

     

     

     

    2,021

     

    Other

     

     

    1,992

     

     

     

    2,083

     

     

     

    2,013

     

     

     

     

    16,414

     

     

     

    16,662

     

     

     

    14,927

     

     

     

     

     

     

     

     

     

     

     

    Property and equipment, at cost

     

     

    62,514

     

     

     

    61,750

     

     

     

    58,548

     

    Accumulated depreciation

     

     

    (33,100

    )

     

     

    (32,703

    )

     

     

    (30,833

    )

     

     

     

    29,414

     

     

     

    29,047

     

     

     

    27,715

     

     

     

     

     

     

     

     

     

     

     

    Investments of insurance subsidiaries

     

     

    569

     

     

     

    553

     

     

     

    477

     

    Investments in and advances to affiliates

     

     

    662

     

     

     

    705

     

     

     

    756

     

    Goodwill and other intangible assets

     

     

    10,093

     

     

     

    9,982

     

     

     

    9,945

     

    Right-of-use operating lease assets

     

     

    2,131

     

     

     

    2,201

     

     

     

    2,207

     

    Other

     

     

    230

     

     

     

    309

     

     

     

    184

     

     

     

     

     

     

     

     

     

     

     

     

     

    $

    59,513

     

     

    $

    59,459

     

     

    $

    56,211

     

     

     

     

     

     

     

     

     

     

     

    LIABILITIES AND STOCKHOLDERS' EQUITY

     

     

     

     

     

     

     

     

     

    Current liabilities:

     

     

     

     

     

     

     

     

     

    Accounts payable

     

    $

    4,276

     

     

    $

    4,235

     

     

    $

    4,233

     

    Accrued salaries

     

     

    2,304

     

     

     

    2,164

     

     

     

    2,127

     

    Other accrued expenses

     

     

    3,899

     

     

     

    3,819

     

     

     

    3,871

     

    Long-term debt due within one year

     

     

    4,698

     

     

     

    4,682

     

     

     

    2,424

     

     

     

     

    15,177

     

     

     

    14,900

     

     

     

    12,655

     

     

     

     

     

     

     

     

     

     

     

    Long-term debt, less debt issuance costs and discounts of $369, $378 and $333

     

     

    38,333

     

     

     

    38,283

     

     

     

    37,169

     

    Professional liability risks

     

     

    1,544

     

     

     

    1,584

     

     

     

    1,557

     

    Right-of-use operating lease obligations

     

     

    1,863

     

     

     

    1,924

     

     

     

    1,903

     

    Income taxes and other liabilities

     

     

    2,041

     

     

     

    1,982

     

     

     

    1,867

     

     

     

     

     

     

     

     

     

     

     

    Stockholders' equity:

     

     

     

     

     

     

     

     

     

    Stockholders' deficit attributable to HCA Healthcare, Inc.

     

     

    (2,499

    )

     

     

    (2,182

    )

     

     

    (1,774

    )

    Noncontrolling interests

     

     

    3,054

     

     

     

    2,968

     

     

     

    2,834

     

     

     

     

    555

     

     

     

    786

     

     

     

    1,060

     

     

     

    $

    59,513

     

     

    $

    59,459

     

     

    $

    56,211

     

    HCA Healthcare, Inc.

    Condensed Consolidated Statements of Cash Flows

    For the Years Ended December 31, 2024 and 2023

    Unaudited

    (Dollars in millions)

     

     

     

    2024

     

     

    2023

     

    Cash flows from operating activities:

     

     

     

     

     

     

    Net income

     

    $

    6,657

     

     

    $

    6,091

     

    Adjustments to reconcile net income to net cash provided by operating activities:

     

     

     

     

     

     

    Increase (decrease) in cash from operating assets and liabilities:

     

     

     

     

     

     

    Accounts receivable

     

     

    (799

    )

     

     

    (935

    )

    Inventories and other assets

     

     

    334

     

     

     

    (126

    )

    Accounts payable and accrued expenses

     

     

    359

     

     

     

    604

     

    Depreciation and amortization

     

     

    3,312

     

     

     

    3,077

     

    Income taxes

     

     

    22

     

     

     

    229

     

    Losses (gains) on sales of facilities

     

     

    (14

    )

     

     

    5

     

    Amortization of debt issuance costs and discounts

     

     

    35

     

     

     

    35

     

    Share-based compensation

     

     

    360

     

     

     

    262

     

    Other

     

     

    248

     

     

     

    189

     

     

     

     

     

     

     

     

    Net cash provided by operating activities

     

     

    10,514

     

     

     

    9,431

     

     

     

     

     

     

     

     

    Cash flows from investing activities:

     

     

     

     

     

     

    Purchase of property and equipment

     

     

    (4,875

    )

     

     

    (4,744

    )

    Acquisition of hospitals and health care entities

     

     

    (266

    )

     

     

    (635

    )

    Sales of hospitals and health care entities

     

     

    328

     

     

     

    193

     

    Change in investments

     

     

    (115

    )

     

     

    (112

    )

    Other

     

     

    (5

    )

     

     

    (19

    )

     

     

     

     

     

     

     

    Net cash used in investing activities

     

     

    (4,933

    )

     

     

    (5,317

    )

     

     

     

     

     

     

     

    Cash flows from financing activities:

     

     

     

     

     

     

    Issuances of long-term debt

     

     

    7,495

     

     

     

    3,224

     

    Net change in revolving credit facilities

     

     

    (1,880

    )

     

     

    (1,020

    )

    Repayment of long-term debt

     

     

    (2,410

    )

     

     

    (909

    )

    Distributions to noncontrolling interests

     

     

    (711

    )

     

     

    (640

    )

    Payment of debt issuance costs

     

     

    (67

    )

     

     

    (31

    )

    Payment of dividends

     

     

    (690

    )

     

     

    (661

    )

    Repurchase of common stock

     

     

    (6,042

    )

     

     

    (3,811

    )

    Other

     

     

    (277

    )

     

     

    (246

    )

     

     

     

     

     

     

     

    Net cash used in financing activities

     

     

    (4,582

    )

     

     

    (4,094

    )

     

     

     

     

     

     

     

    Effect of exchange rate changes on cash and cash equivalents

     

     

    (1

    )

     

     

    7

     

     

     

     

     

     

     

     

    Change in cash and cash equivalents

     

     

    998

     

     

     

    27

     

    Cash and cash equivalents at beginning of period

     

     

    935

     

     

     

    908

     

     

     

     

     

     

     

     

    Cash and cash equivalents at end of period

     

    $

    1,933

     

     

    $

    935

     

     

     

     

     

     

     

     

    Interest payments

     

    $

    1,938

     

     

    $

    1,892

     

    Income tax payments, net

     

    $

    1,844

     

     

    $

    1,386

     

    HCA Healthcare, Inc.

    Operating Statistics

     

     

     

    Fourth Quarter

     

     

    For the Years

    Ended December 31,

     

     

     

    2024

     

     

    2023

     

     

    2024

     

     

    2023

     

    Operations:

     

     

     

     

     

     

     

     

     

     

     

     

    Number of Hospitals

     

     

    190

     

     

     

    186

     

     

     

    190

     

     

     

    186

     

    Number of Freestanding Outpatient Surgery Centers*

     

     

    124

     

     

     

    124

     

     

     

    124

     

     

     

    124

     

    Licensed Beds at End of Period

     

     

    49,985

     

     

     

    49,588

     

     

     

    49,985

     

     

     

    49,588

     

    Weighted Average Beds in Service

     

     

    42,705

     

     

     

    42,072

     

     

     

    42,633

     

     

     

    41,873

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Reported:

     

     

     

     

     

     

     

     

     

     

     

     

    Admissions

     

     

    559,170

     

     

     

    544,554

     

     

     

    2,236,595

     

     

     

    2,130,728

     

    % Change

     

     

    2.7

    %

     

     

     

     

     

    5.0

    %

     

     

     

    Equivalent Admissions

     

     

    1,007,623

     

     

     

    974,561

     

     

     

    3,990,085

     

     

     

    3,788,434

     

    % Change

     

     

    3.4

    %

     

     

     

     

     

    5.3

    %

     

     

     

    Revenue per Equivalent Admission

     

    $

    18,146

     

     

    $

    17,755

     

     

    $

    17,695

     

     

    $

    17,149

     

    % Change

     

     

    2.2

    %

     

     

     

     

     

    3.2

    %

     

     

     

    Inpatient Revenue per Admission

     

    $

    19,737

     

     

    $

    18,992

     

     

    $

    19,050

     

     

    $

    18,201

     

    % Change

     

     

    3.9

    %

     

     

     

     

     

    4.7

    %

     

     

     

    Patient Days

     

     

    2,691,710

     

     

     

    2,674,331

     

     

     

    10,826,574

     

     

     

    10,483,236

     

    % Change

     

     

    0.6

    %

     

     

     

     

     

    3.3

    %

     

     

     

    Equivalent Patient Days

     

     

    4,850,820

     

     

     

    4,786,197

     

     

     

    19,314,608

     

     

     

    18,639,194

     

    % Change

     

     

    1.4

    %

     

     

     

     

     

    3.6

    %

     

     

     

    Inpatient Surgery Cases

     

     

    135,643

     

     

     

    132,417

     

     

     

    540,704

     

     

     

    528,845

     

    % Change

     

     

    2.4

    %

     

     

     

     

     

    2.2

    %

     

     

     

    Outpatient Surgery Cases

     

     

    263,832

     

     

     

    270,286

     

     

     

    1,024,998

     

     

     

    1,044,415

     

    % Change

     

     

    -2.4

    %

     

     

     

     

     

    -1.9

    %

     

     

     

    Emergency Room Visits

     

     

    2,498,429

     

     

     

    2,452,395

     

     

     

    9,789,265

     

     

     

    9,342,783

     

    % Change

     

     

    1.9

    %

     

     

     

     

     

    4.8

    %

     

     

     

    Outpatient Revenues as a Percentage of Patient Revenues

     

     

    37.9

    %

     

     

    38.4

    %

     

     

    37.8

    %

     

     

    38.3

    %

    Average Length of Stay (days)

     

     

    4.814

     

     

     

    4.911

     

     

     

    4.841

     

     

     

    4.920

     

    Occupancy**

     

     

    71.7

    %

     

     

    72.5

    %

     

     

    72.7

    %

     

     

    72.3

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

    Same Facility:

     

     

     

     

     

     

     

     

     

     

     

     

    Admissions

     

     

    552,610

     

     

     

    536,350

     

     

     

    2,204,148

     

     

     

    2,101,839

     

    % Change

     

     

    3.0

    %

     

     

     

     

     

    4.9

    %

     

     

     

    Equivalent Admissions

     

     

    980,330

     

     

     

    950,949

     

     

     

    3,881,505

     

     

     

    3,713,950

     

    % Change

     

     

    3.1

    %

     

     

     

     

     

    4.5

    %

     

     

     

    Revenue per Equivalent Admission

     

    $

    18,185

     

     

    $

    17,674

     

     

    $

    17,625

     

     

    $

    17,071

     

    % Change

     

     

    2.9

    %

     

     

     

     

     

    3.2

    %

     

     

     

    Inpatient Revenue per Admission

     

    $

    19,835

     

     

    $

    19,006

     

     

    $

    19,085

     

     

    $

    18,185

     

    % Change

     

     

    4.4

    %

     

     

     

     

     

    4.9

    %

     

     

     

    Inpatient Surgery Cases

     

     

    134,482

     

     

     

    130,779

     

     

     

    534,330

     

     

     

    523,074

     

    % Change

     

     

    2.8

    %

     

     

     

     

     

    2.2

    %

     

     

     

    Outpatient Surgery Cases

     

     

    257,663

     

     

     

    261,155

     

     

     

    997,043

     

     

     

    1,013,752

     

    % Change

     

     

    -1.3

    %

     

     

     

     

     

    -1.6

    %

     

     

     

    Emergency Room Visits

     

     

    2,466,784

     

     

     

    2,410,050

     

     

     

    9,642,016

     

     

     

    9,192,154

     

    % Change

     

     

    2.4

    %

     

     

     

     

     

    4.9

    %

     

     

     

     

    * Excludes freestanding endoscopy centers (26 centers at December 31, 2024 and 24 centers at December 31, 2023).

    ** Reflects the rate of occupancy (patient days and observations) based on weighted average beds in service.

    HCA Healthcare, Inc.

    Supplemental Non-GAAP Disclosures

    Operating Results Summary

    (Dollars in millions, except per share amounts)

     

     

     

    Fourth Quarter

     

     

    For the Years

    Ended December 31,

     

     

     

    2024

     

     

    2023

     

     

    2024

     

     

    2023

     

    Revenues

     

    $

    18,285

     

     

    $

    17,303

     

     

    $

    70,603

     

     

    $

    64,968

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Net income attributable to HCA Healthcare, Inc.

     

    $

    1,438

     

     

    $

    1,607

     

     

    $

    5,760

     

     

    $

    5,242

     

    Losses (gains) on sales of facilities (net of tax)

     

     

    149

     

     

     

    (9

    )

     

     

    (11

    )

     

     

    12

     

    Net income attributable to HCA Healthcare, Inc., as adjusted (a)

     

     

    1,587

     

     

     

    1,598

     

     

     

    5,749

     

     

     

    5,254

     

    Depreciation and amortization

     

     

    856

     

     

     

    789

     

     

     

    3,312

     

     

     

    3,077

     

    Interest expense

     

     

    528

     

     

     

    491

     

     

     

    2,061

     

     

     

    1,938

     

    Provision for income taxes

     

     

    493

     

     

     

    486

     

     

     

    1,863

     

     

     

    1,608

     

    Net income attributable to noncontrolling interests

     

     

    248

     

     

     

    254

     

     

     

    897

     

     

     

    849

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjusted EBITDA (a)

     

     

    3,712

     

     

    $

    3,618

     

     

    $

    13,882

     

     

    $

    12,726

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjusted EBITDA margin (a)

     

     

    20.3

    %

     

     

    20.9

    %

     

     

    19.7

    %

     

     

    19.6

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

    Diluted earnings per share:

     

     

     

     

     

     

     

     

     

     

     

     

    Net income attributable to HCA Healthcare, Inc.

     

    $

    5.63

     

     

    $

    5.93

     

     

    $

    22.00

     

     

    $

    18.97

     

    Losses (gains) on sales of facilities

     

     

    0.59

     

     

     

    (0.03

    )

     

     

    (0.04

    )

     

     

    0.04

     

    Net income attributable to HCA Healthcare, Inc., as adjusted (a)

     

    $

    6.22

     

     

    $

    5.90

     

     

    $

    21.96

     

     

    $

    19.01

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Shares used in computing diluted earnings per share (millions)

     

     

    255.310

     

     

     

    271.186

     

     

     

    261.806

     

     

     

    276.412

     

    ______________

    (a)

    Net income attributable to HCA Healthcare, Inc., as adjusted, diluted earnings per share, as adjusted, and Adjusted EBITDA should not be considered as measures of financial performance under generally accepted accounting principles ("GAAP"). These non-GAAP financial measures are adjusted to exclude losses (gains) on sales of facilities and losses on retirement of debt. We believe net income attributable to HCA Healthcare, Inc., as adjusted, diluted earnings per share, as adjusted, and Adjusted EBITDA are important measures that supplement discussions and analysis of our results of operations. We believe it is useful to investors to provide disclosures of our results of operations on the same basis used by management. Management relies upon net income attributable to HCA Healthcare, Inc., as adjusted, diluted earnings per share, as adjusted, and Adjusted EBITDA as the primary measures to review and assess operating performance of its health care facilities and their management teams.

     

     

     

    Management and investors review both the overall performance (including net income attributable to HCA Healthcare, Inc., as adjusted, diluted earnings per share, as adjusted, and GAAP net income attributable to HCA Healthcare, Inc.) and operating performance (Adjusted EBITDA) of our health care facilities. Adjusted EBITDA and the Adjusted EBITDA margin (Adjusted EBITDA divided by revenues) are utilized by management and investors to compare our current operating results with the corresponding periods during the previous year and to compare our operating results with other companies in the health care industry. It is reasonable to expect that adjustments, including losses (gains) on sales of facilities and losses on retirement of debt will occur in future periods, but the amounts recognized can vary significantly from period to period, do not directly relate to the ongoing operations of our health care facilities and complicate period comparisons of our results of operations and operations comparisons with other health care companies.

     

     

     

    Net income attributable to HCA Healthcare, Inc., as adjusted, diluted earnings per share, as adjusted, and Adjusted EBITDA are not measures of financial performance under GAAP, and should not be considered as alternatives to net income attributable to HCA Healthcare, Inc. as a measure of operating performance or cash flows from operating, investing and financing activities as a measure of liquidity. Because net income attributable to HCA Healthcare, Inc., as adjusted, diluted earnings per share, as adjusted, and Adjusted EBITDA are not measurements determined in accordance with GAAP and are susceptible to varying calculations, net income attributable to HCA Healthcare, Inc., as adjusted, diluted earnings per share, as adjusted, and Adjusted EBITDA, as presented, may not be comparable to other similarly titled measures presented by other companies.

    HCA Healthcare, Inc.

    Supplemental Non-GAAP Disclosures

    2025 Operating Results Forecast

    (Dollars in millions, except per share amounts)

     

     

     

    For the Year Ending

     

     

     

    December 31, 2025

     

     

     

    Low

     

     

    High

     

    Revenues

     

    $

    72,800

     

     

    $

    75,800

     

     

     

     

     

     

     

     

    Net income attributable to HCA Healthcare, Inc. (a)

     

    $

    5,850

     

     

    $

    6,290

     

    Depreciation and amortization

     

     

    3,495

     

     

     

    3,565

     

    Interest expense

     

     

    2,230

     

     

     

    2,320

     

    Provision for income taxes

     

     

    1,800

     

     

     

    1,950

     

    Net income attributable to noncontrolling interests

     

     

    925

     

     

     

    975

     

     

     

     

     

     

     

     

    Adjusted EBITDA (a) (b)

     

    $

    14,300

     

     

    $

    15,100

     

     

     

     

     

     

     

     

    Diluted earnings per share:

     

     

     

     

     

     

    Net income attributable to HCA Healthcare, Inc.

     

    $

    24.05

     

     

    $

    25.85

     

     

     

     

     

     

     

     

    Shares used in computing diluted earnings per share (millions)

     

     

    243.000

     

     

     

    243.000

     

    The Company's forecasted guidance is based on current plans and expectations and is subject to a number of known and unknown uncertainties and risks.

    ______________

    (a)

    The Company does not forecast the impact of items such as, but not limited to, losses (gains) on sales of facilities, losses on retirement of debt, legal claim costs (benefits) and impairments of long-lived assets because the Company does not believe that it can forecast these items with sufficient accuracy.

     

     

    (b)

    Adjusted EBITDA should not be considered a measure of financial performance under generally accepted accounting principles ("GAAP"). We believe Adjusted EBITDA is an important measure that supplements discussions and analysis of our results of operations. We believe it is useful to investors to provide disclosures of our results of operations on the same basis used by management. Management relies upon Adjusted EBITDA as a primary measure to review and assess operating performance of its health care facilities and their management teams.

     

     

     

    Management and investors review both the overall performance (including net income attributable to HCA Healthcare, Inc.) and operating performance (Adjusted EBITDA) of our healthcare facilities. Adjusted EBITDA is utilized by management and investors to compare our current operating results with the corresponding periods during the previous year and to compare our operating results with other companies in the health care industry.

     

     

     

    Adjusted EBITDA is not a measure of financial performance under GAAP and should not be considered as an alternative to net income attributable to HCA Healthcare, Inc. as a measure of operating performance or cash flows from operating, investing and financing activities as a measure of liquidity. Because Adjusted EBITDA is not a measurement determined in accordance with GAAP and is susceptible to varying calculations, Adjusted EBITDA, as presented, may not be comparable to other similarly titled measures presented by other companies.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250124034956/en/

    INVESTOR CONTACT:

    Frank Morgan

    615-344-2688

    MEDIA CONTACT:

    Harlow Sumerford

    615-344-1851

    Get the next $HCA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HCA

    DatePrice TargetRatingAnalyst
    4/15/2025$336.00Outperform → Neutral
    Robert W. Baird
    12/17/2024$380.00Neutral
    Analyst
    11/25/2024$400.00 → $320.00Equal Weight → Underweight
    Wells Fargo
    11/22/2024Outperform → Mkt Perform
    Raymond James
    10/11/2024$475.00Overweight
    KeyBanc Capital Markets
    9/3/2024$427.00Equal-Weight
    Morgan Stanley
    5/30/2024$396.00Outperform
    Robert W. Baird
    3/6/2024$356.00Overweight
    Barclays
    More analyst ratings

    $HCA
    Financials

    Live finance-specific insights

    See more
    • HCA Healthcare Reports First Quarter 2025 Results

      HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the first quarter ended March 31, 2025. Key first quarter metrics (all percentage changes compare 1Q 2025 to 1Q 2024 unless otherwise noted): Revenues totaled $18.321 billion Net income attributable to HCA Healthcare, Inc. totaled $1.610 billion, or $6.45 per diluted share Adjusted EBITDA totaled $3.733 billion Cash flows from operating activities totaled $1.651 billion Same facility admissions increased 2.6 percent and same facility equivalent admissions increased 2.8 percent "The solid fundamentals we saw in our business the past several quarters continued into the first quarter of 2025," said

      4/25/25 7:30:00 AM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • HCA Healthcare, Inc. 1st Quarter 2025 Earnings Conference Call

      HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 1Q 2025 Earnings Call When: Friday, April 25, 2025 at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, [email protected] If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/news/home/20250404757460/en/ INVESTOR CONTACT: Frank Morgan

      4/4/25 4:00:00 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • HCA Healthcare Reports Fourth Quarter 2024 Results and Provides 2025 Guidance

      HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the fourth quarter ended December 31, 2024. Key fourth quarter metrics (all percentage changes compare 4Q 2024 to 4Q 2023 unless otherwise noted): Revenues totaled $18.285 billion Net income attributable to HCA Healthcare, Inc. totaled $1.438 billion, or $5.63 per diluted share (which includes an estimated $0.60 per diluted share unfavorable impact from Hurricanes Helene and Milton) Adjusted EBITDA totaled $3.712 billion Cash flows from operating activities totaled $2.559 billion Same facility admissions increased 3.0 percent and same facility equivalent admissions increased 3.1 percent "

      1/24/25 7:30:00 AM ET
      $HCA
      Hospital/Nursing Management
      Health Care

    $HCA
    Leadership Updates

    Live Leadership Updates

    See more
    • HCA Healthcare Announces HCA Healthcare Foundation's Support of Girl Scouts Mental Wellness Patch Programs

      HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that the HCA Healthcare Foundation has helped Girl Scouts of the USA (GSUSA) launch a new series of Mental Wellness Patch Programs to address mental wellness among girls in 4th through 12th grade. This is a result of the HCA Healthcare Foundation's $1.38 million grant to GSUSA, through its Healthier Tomorrow Fund, which was announced last year. "The HCA Healthcare Foundation has a long history of partnering with Girl Scouts nationally and locally. We are proud to deepen our partnership with Girl Scouts on this research-based mental wellness program," said Joanne Pulles, vice president of com

      9/19/23 8:30:00 AM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • HCA Healthcare Appoints Jyric Sims President of Company's West Florida Division

      HCA Healthcare, Inc. (NYSE:HCA) today announced Jyric Sims, Ph.D., will become president of the company's West Florida Division, effective June 12. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230420005364/en/Jyric Sims, Ph.D. (Photo: Business Wire) Sims, who currently is CEO of HCA Healthcare's Medical City Plano and Medical City Frisco hospitals, will succeed Ravi Chari, M.D., who recently announced he will retire after 15 years with the company to pursue opportunities in early-stage healthcare companies. A more than 20-year healthcare veteran, Sims has been with HCA Healthcare since 2011. He has served as chief executive

      4/20/23 8:30:00 AM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • HCA Healthcare Announces Retirement of Longtime Senior Executive Chuck Hall

      HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that Chuck Hall, HCA Healthcare's National Group president, will retire at the end of the year after nearly 36 years with the organization. Currently, Hall is responsible for HCA Healthcare's operations at 96 hospitals across 13 states. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220817005233/en/HCA Healthcare Announces Retirement of Longtime Senior Executive Chuck Hall (Photo: Business Wire) Over more than three decades, Hall has been influential in many successful initiatives that will benefit the company for years to come, inc

      8/17/22 8:30:00 AM ET
      $HCA
      Hospital/Nursing Management
      Health Care

    $HCA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • HCA Healthcare, Inc. to Present at May Healthcare Conference

      HCA Healthcare, Inc. (NYSE:HCA) is scheduled to present at the following healthcare conferences: May 13, 2025 at 9:20am PT at the Bank of America 2025 Healthcare Conference. A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relations section of the Company's website, www.hcahealthcare.com. Dates and times may be subject to change, please check the conference schedule or the Investor Relations section of the Company's website for the latest information. About HCA Healthcare Nashville-based HCA Healthcare is one of the nation's leading providers of healthcare services comprising 192 hospitals and ap

      5/5/25 4:30:00 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • HCA Healthcare Reports First Quarter 2025 Results

      HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the first quarter ended March 31, 2025. Key first quarter metrics (all percentage changes compare 1Q 2025 to 1Q 2024 unless otherwise noted): Revenues totaled $18.321 billion Net income attributable to HCA Healthcare, Inc. totaled $1.610 billion, or $6.45 per diluted share Adjusted EBITDA totaled $3.733 billion Cash flows from operating activities totaled $1.651 billion Same facility admissions increased 2.6 percent and same facility equivalent admissions increased 2.8 percent "The solid fundamentals we saw in our business the past several quarters continued into the first quarter of 2025," said

      4/25/25 7:30:00 AM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • Two Large Clinical Trials Find a Highly Effective Method to Select Appropriate Antibiotics for Patients Hospitalized With Abdominal or Skin and Soft Tissue Infection

      Computerized alerts tailored to each patient help identify which antibiotic is best suited to treat patients hospitalized with common infections in two 92-hospital trials. Two large multi-state studies funded by the National Institutes of Health and led by the University of California, Irvine, Harvard Pilgrim Health Care Institute, and HCA Healthcare have found a highly effective method to improve antibiotic selection for patients who are hospitalized with abdominal or skin and soft tissue infection to reduce their risk of antibiotic resistance. Results were published in JAMA Surgery and JAMA Internal Medicine and highlighted at the Congress of the European Society of Clinical Microbiology

      4/10/25 1:00:00 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care

    $HCA
    SEC Filings

    See more

    $HCA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $HCA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $HCA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • SEC Form 10-Q filed by HCA Healthcare Inc.

      10-Q - HCA Healthcare, Inc. (0000860730) (Filer)

      5/1/25 4:30:20 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • HCA Healthcare Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - HCA Healthcare, Inc. (0000860730) (Filer)

      4/29/25 4:39:03 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • HCA Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

      8-K - HCA Healthcare, Inc. (0000860730) (Filer)

      4/25/25 7:48:16 AM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • SEC Form SC 13G/A filed by HCA Healthcare Inc. (Amendment)

      SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)

      2/14/24 5:10:03 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • SEC Form SC 13G/A filed by HCA Healthcare Inc. (Amendment)

      SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)

      2/14/24 5:06:57 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • SEC Form SC 13G/A filed by HCA Healthcare Inc. (Amendment)

      SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)

      2/13/24 5:06:27 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • Large owner Bank Of America Corp /De/ bought $88,208 worth of shares (3,436 units at $25.67) and sold $79,816 worth of shares (3,178 units at $25.12) (SEC Form 4)

      4 - HCA Healthcare, Inc. (0000860730) (Issuer)

      3/28/25 4:11:57 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • HCA downgraded by Robert W. Baird with a new price target

      Robert W. Baird downgraded HCA from Outperform to Neutral and set a new price target of $336.00

      4/15/25 9:26:09 AM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • Analyst resumed coverage on HCA with a new price target

      Analyst resumed coverage of HCA with a rating of Neutral and set a new price target of $380.00

      12/17/24 8:04:06 AM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • HCA downgraded by Wells Fargo with a new price target

      Wells Fargo downgraded HCA from Equal Weight to Underweight and set a new price target of $320.00 from $400.00 previously

      11/25/24 7:44:35 AM ET
      $HCA
      Hospital/Nursing Management
      Health Care

    $HCA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP and CFO Marks Mike A gifted 935 shares, received a gift of 647 shares, disposed of $203,529 worth of shares (573 units at $355.20) and acquired $203,529 worth of shares (573 units at $355.20), closing all direct ownership in the company (SEC Form 4)

      4 - HCA Healthcare, Inc. (0000860730) (Issuer)

      5/8/25 6:40:51 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • Director Frist William R was granted 1,026 shares and acquired $3,577,854 worth of shares (10,505 units at $340.60), increasing direct ownership by 9% to 12,931 units (SEC Form 4)

      4 - HCA Healthcare, Inc. (0000860730) (Issuer)

      5/1/25 7:30:55 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • Director Frist Thomas F Iii was granted 1,320 shares, increasing direct ownership by 10% to 14,817 units (SEC Form 4)

      4 - HCA Healthcare, Inc. (0000860730) (Issuer)

      5/1/25 6:49:02 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care